Medprin Regenerative Medical Technologies Co., Ltd. clinical trials
The registry lists 8 studies whose lead sponsor is Medprin Regenerative Medical Technologies Co., Ltd.. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 21, 2026.
Our grouping of 1 registry name, not the registry’s. See them and correct one ↓
- 8studies on the registry
- 2open to participants now
- 1phase 3 study under way
Get an email when these change. Save the Medprin Regenerative Medical Technologies Co., Ltd. studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
All 8 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
Over the years
- 214
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 226
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Medprin Regenerative Medical Technologies Co., Ltd..
- Medprin Regenerative Medical Technologies Co., Ltd.8 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 8 of 8.
- Absorbable Hemostatic Fluid Gelatin TrialNot yet recruitingNCT07830797Phase 3
- Immiseal™ Dural Sealant Post-Market Registry StudyRecruitingNCT07651826
- A Trial of Absorbable Medical Adhesive for Prevention of CSF LeakCompletedNCT07768553Phase 3
- A Trial of Absorbable Regenerated Oxidized Cellulose for Surgical Hemostasis)CompletedNCT07764055Phase 3
- Dural Medical Adhesive for Watertight Sealing in Dural RepairCompletedNCT07754344Phase 3
- Post-market Clinical Follow-up Plan of StypCel™ Absorbable HemostatCompletedNCT07199439
- Study to Evaluate the Safety and Efficacy of Dural Repair Patch in Neurosurgical RepairsStatus unknownNCT02129114Not applicable
- Safety and Efficacy Study of Regen Sling to Treatment SUIStatus unknownNCT02106299Phase 3